DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol ▼ | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0400966 | Non-alcoholic Fatty Liver Disease | ELOVL2 | 54898 | ELOVL fatty acid elongase 2 | Q9NXB9 |
C1956346 | Coronary Artery Disease | ELOVL2 | 54898 | ELOVL fatty acid elongase 2 | Q9NXB9 |
C0027051 | Myocardial Infarction | ELOVL2 | 54898 | ELOVL fatty acid elongase 2 | Q9NXB9 |
C0742343 | Acute Chest Syndrome | ELOVL2 | 54898 | ELOVL fatty acid elongase 2 | Q9NXB9 |
C1510586 | Autism Spectrum Disorders | ELOVL2 | 54898 | ELOVL fatty acid elongase 2 | Q9NXB9 |
C2239176 | Liver carcinoma | ELOVL2 | 54898 | ELOVL fatty acid elongase 2 | Q9NXB9 |
C0238463 | Papillary thyroid carcinoma | ELOVL2 | 54898 | ELOVL fatty acid elongase 2 | Q9NXB9 |
C0000889 | Acanthosis Nigricans | ELOVL1 | 64834 | ELOVL fatty acid elongase 1 | Q9BW60 |
C0085636 | Photophobia | ELOVL1 | 64834 | ELOVL fatty acid elongase 1 | Q9BW60 |
C0013238 | Dry Eye Syndromes | ELOVL1 | 64834 | ELOVL fatty acid elongase 1 | Q9BW60 |
C0162309 | Adrenoleukodystrophy | ELOVL1 | 64834 | ELOVL fatty acid elongase 1 | Q9BW60 |
C1527231 | Adrenomyeloneuropathy | ELOVL1 | 64834 | ELOVL fatty acid elongase 1 | Q9BW60 |
C0011603 | Dermatitis | ELOVL1 | 64834 | ELOVL fatty acid elongase 1 | Q9BW60 |
C0027651 | Neoplasms | ELOVL1 | 64834 | ELOVL fatty acid elongase 1 | Q9BW60 |
C0020456 | Hyperglycemia | ELOVL1 | 64834 | ELOVL fatty acid elongase 1 | Q9BW60 |
C0005697 | Neurogenic Urinary Bladder | ELOVL1 | 64834 | ELOVL fatty acid elongase 1 | Q9BW60 |
C3810100 | FANCONI RENOTUBULAR SYNDROME 3 | EHHADH | 1962 | enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Q08426 |
C4551503 | FANCONI RENOTUBULAR SYNDROME 1 | EHHADH | 1962 | enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Q08426 |
C0041296 | Tuberculosis | EHHADH | 1962 | enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Q08426 |
C0342790 | Carnitine palmitoyl transferase 2 deficiency | EHHADH | 1962 | enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Q08426 |
C0013146 | Drug abuse | EHHADH | 1962 | enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Q08426 |
C0013222 | Drug Use Disorders | EHHADH | 1962 | enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Q08426 |
C0236969 | Substance-Related Disorders | EHHADH | 1962 | enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Q08426 |
C0033687 | Proteinuria | EHHADH | 1962 | enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Q08426 |
C3888018 | Congenital Hyperinsulinism | EHHADH | 1962 | enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Q08426 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024